VXRT shares fall on plans to delay COVID-19 clinical trials (NASDAQ:VXRT)
aajan Issuing its fourth-quarter 2022 financial data on Wednesday, vaccine developer Vaxart (NASDAQ:VXRT) announced a reorganization of its portfolio to ...
aajan Issuing its fourth-quarter 2022 financial data on Wednesday, vaccine developer Vaxart (NASDAQ:VXRT) announced a reorganization of its portfolio to ...